Azarga (brinzolamide;timolol)
- Region
- 🇪🇺 EU
- Active substance
- brinzolamide;timolol
- Company
- Novartis Europharm Limited
- Status
- Authorised
- Therapeutic area
- Glaucoma, Open-Angle; Ocular Hypertension
- EU approval
- Tue 25 Nov 2008
- Application
- EMEA/H/C/000960
- ATC
- S01ED51
- Official record
- www.ema.europa.eu
Indication
Decrease of intraocular pressure (IOP) in adult patients with open angle glaucoma or ocular hypertension for whom monotherapy provides insufficient IOP reduction.
Regulatory milestones
No milestones recorded in the last year.
Follow Azarga
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.